Seed amplification assays have been implemented in Parkinson's disease to reveal disease-specific misfolded alpha-synuclein aggregates in biospecimens. While the assays' qualitative dichotomous seeding response is valuable to stratify and enrich cohorts for alpha-synuclein pathology in general, more quantitative parameters that are associated with clinical dynamics of disease progression and that might potentially serve as exploratory outcome measures in clinical trials targeting alpha-synuclein would add important information. To evaluate whether the seeding kinetic parameters time required to reach the seeding threshold (LAG phase), the peak of fluorescence response (Imax), and the area under the curve (AUC) are associated with clinical trajectories, we analyzed LAG, Imax, and AUC in relation to the development of cognitive decline in a longitudinal cohort of 199 people with Parkinson's disease with positive CSF alpha-synuclein seeding status. Patients were stratified into tertiles based on their individual CSF alpha-synuclein seeding kinetic properties. The effect of the kinetic parameters on longitudinal development of cognitive impairment defined by MoCA <= 25 was analyzed by Cox-Regression. Patients with a higher number of positive seeding replicates and tertile groups of shorter LAG, higher Imax, and higher AUC showed a higher prevalence of and a shorter duration until cognitive impairment longitudinally (3, 6, and 3 years earlier with p <= 0.001, respectively). Results remained similar in separate subgroup analyses of patients with and without GBA mutation. We conclude that a more prominent alpha-synuclein seeding kinetic profile translates into a more rapid development of cognitive decline.

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease / Brockmann, Kathrin; Lerche, Stefanie; Baiardi, Simone; Rossi, Marcello; Wurster, Isabel; Quadalti, Corinne; Roeben, Benjamin; Mammana, Angela; Zimmermann, Milan; Hauser, Ann‑Kathrin; Deuschle, Christian; Schulte, Claudia; Liepelt-Scarfone, Inga; Gasser, Thomas; Parchi, Piero. - In: NPJ PARKINSON'S DISEASE. - ISSN 2373-8057. - ELETTRONICO. - 10:1(2024), pp. 24.1-24.9. [10.1038/s41531-023-00627-5]

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease

Baiardi, Simone;Rossi, Marcello;Quadalti, Corinne;Mammana, Angela;Parchi, Piero
2024

Abstract

Seed amplification assays have been implemented in Parkinson's disease to reveal disease-specific misfolded alpha-synuclein aggregates in biospecimens. While the assays' qualitative dichotomous seeding response is valuable to stratify and enrich cohorts for alpha-synuclein pathology in general, more quantitative parameters that are associated with clinical dynamics of disease progression and that might potentially serve as exploratory outcome measures in clinical trials targeting alpha-synuclein would add important information. To evaluate whether the seeding kinetic parameters time required to reach the seeding threshold (LAG phase), the peak of fluorescence response (Imax), and the area under the curve (AUC) are associated with clinical trajectories, we analyzed LAG, Imax, and AUC in relation to the development of cognitive decline in a longitudinal cohort of 199 people with Parkinson's disease with positive CSF alpha-synuclein seeding status. Patients were stratified into tertiles based on their individual CSF alpha-synuclein seeding kinetic properties. The effect of the kinetic parameters on longitudinal development of cognitive impairment defined by MoCA <= 25 was analyzed by Cox-Regression. Patients with a higher number of positive seeding replicates and tertile groups of shorter LAG, higher Imax, and higher AUC showed a higher prevalence of and a shorter duration until cognitive impairment longitudinally (3, 6, and 3 years earlier with p <= 0.001, respectively). Results remained similar in separate subgroup analyses of patients with and without GBA mutation. We conclude that a more prominent alpha-synuclein seeding kinetic profile translates into a more rapid development of cognitive decline.
2024
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease / Brockmann, Kathrin; Lerche, Stefanie; Baiardi, Simone; Rossi, Marcello; Wurster, Isabel; Quadalti, Corinne; Roeben, Benjamin; Mammana, Angela; Zimmermann, Milan; Hauser, Ann‑Kathrin; Deuschle, Christian; Schulte, Claudia; Liepelt-Scarfone, Inga; Gasser, Thomas; Parchi, Piero. - In: NPJ PARKINSON'S DISEASE. - ISSN 2373-8057. - ELETTRONICO. - 10:1(2024), pp. 24.1-24.9. [10.1038/s41531-023-00627-5]
Brockmann, Kathrin; Lerche, Stefanie; Baiardi, Simone; Rossi, Marcello; Wurster, Isabel; Quadalti, Corinne; Roeben, Benjamin; Mammana, Angela; Zimmermann, Milan; Hauser, Ann‑Kathrin; Deuschle, Christian; Schulte, Claudia; Liepelt-Scarfone, Inga; Gasser, Thomas; Parchi, Piero
File in questo prodotto:
File Dimensione Formato  
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.28 MB
Formato Adobe PDF
1.28 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/961162
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact